Dr. Reddy’s Laboratories Ltd ADR (RDY)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE
Market Cap: $12.29B
Last updated: Nov 17, 2026 at 4:37 PM ET
Dr. Reddy’s Laboratories Ltd ADR (RDY) Stock Chart
Dr. Reddy’s Laboratories Ltd ADR (RDY) has a latest price of $14.80 on Nov 17, 2026, 4.5% below its 52-week high of $15.49. Its price rose 6.9% over the past 12 months. The month-end price rose 43.7% over the 10 years through Oct 2026, a compound annual rate of 3.7%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $16.69 in Aug 2024 and its lowest $5.70 in May 2018, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart RDY with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for RDY.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 22.2%, and over 6 months it rose 10.8%. The month-end price rose 8.8% over the 3 years through Oct 2026, a compound annual rate of 2.8%.
| Period | Change |
|---|---|
| 1 month | +13.1% |
| 3 months | +22.2% |
| 6 months | +10.8% |
| 12 months | +6.9% |
| 12 months, with dividends | +8.0% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +8.8% | +2.8% |
| 5 years | +15.3% | +2.9% |
| 10 years | +43.7% | +3.7% |
Price by Year
Its best calendar year was 2020, when the price rose 75.7%, and its weakest was 2022, when it fell 20.9%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $14.17 | +0.9% |
| 2025 | $14.04 | -11.1% |
| 2024 | $15.79 | +13.5% |
| 2023 | $13.92 | +34.5% |
| 2022 | $10.35 | -20.9% |
| 2021 | $13.08 | -8.2% |
| 2020 | $14.26 | +75.7% |
| 2019 | $8.12 | +7.6% |
| 2018 | $7.54 | +0.4% |
| 2017 | $7.51 | -17.0% |
Trading Range
The price is 12.5% above its 50-day average of $13.15 and 11.8% above its 200-day average of $13.24.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $14.80 | |
| 52-week high | $15.49 | -4.5% |
| 52-week low | $11.28 | +31.2% |
| 50-day average | $13.15 | +12.5% |
| 200-day average | $13.24 | +11.8% |
Price Risk
Over 3 years, its largest fall from a peak was 32.0%.
| Measure | Value |
|---|---|
| 1-year beta | 0.35 |
| Largest fall, 1 year | -26.0% |
| Largest fall, 3 years | -32.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About RDY
What is RDY's 1-year price change?
Dr. Reddy’s Laboratories Ltd ADR's price rose 6.9% over the past 12 months. With dividends included, the 12-month total return was 8.0%.
What is RDY's 5-year price change?
Dr. Reddy’s Laboratories Ltd ADR's month-end price rose 15.3% over the 5 years through Oct 2026, a compound annual rate of 2.9%. These figures leave out dividends.
What is RDY's 52-week high and low?
Dr. Reddy’s Laboratories Ltd ADR's 52-week high is $15.49 and its 52-week low is $11.28. Its latest price of $14.80 on Nov 17, 2026 is 4.5% below the high.
What is RDY's beta?
Dr. Reddy’s Laboratories Ltd ADR's 1-year beta against the S&P 500 is 0.35, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 26.0%.
Is the RDY chart free?
Yes. Advanced Charting for RDY is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
RDY pages: Overview, Dividends, Charting, Financials, Statistics, Valuation, Competitors